logo.jpg.jpg
ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products
June 22, 2022 09:00 ET | ViaDerma, Inc.
LOS ANGELES, June 22, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces plans to conduct additional internal quality control testing for their new Vitastem products....
logo.jpg.jpg
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
March 31, 2022 05:00 ET | ViaDerma, Inc.
LOS ANGELES, March 31, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces the release of its 2021 Annual Report on the OTC Markets. The Company ended the year with...
logo.jpg.jpg
ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra
October 04, 2021 05:00 ET | ViaDerma, Inc.
LOS ANGELES, Oct. 04, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) is pleased to announce they are launching two new and improved formulas for its top selling product,...
logo.jpg.jpg
ViaDerma, Inc. Files Amended Financial Statements
August 24, 2021 10:23 ET | ViaDerma, Inc.
LOS ANGELES, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) published a Quarterly Report for the three months ended March 31, 2021, on the OTC Markets website...
logo.jpg.jpg
ViaDerma, Inc. Provides Updates on Current Business Activities
June 24, 2021 05:00 ET | ViaDerma, Inc.
LOS ANGELES, June 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to provide an update on current business activities. The Company has finalized a ten-year $12...
logo.jpg.jpg
ViaDerma, Inc. Announces Expansion of its Current Licensing Agreement and Provides Additional Company Updates
June 02, 2021 05:00 ET | ViaDerma, Inc.
LOS ANGELES, June 02, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to announce they have expanded their current licensing agreement with a home health wound care...
logo.jpg.jpg
ViaDerma, Inc. Nearing Initial Order from Large Hospital Network
May 13, 2021 05:00 ET | ViaDerma, Inc.
LOS ANGELES, May 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announced they are nearing the end of their discussions with a major healthcare network to finalize an...
logo.jpg.jpg
ViaDerma, Inc. Provides Preliminary Revenue Estimates and Highlights for its Record Breaking 1st Quarter
April 08, 2021 05:00 ET | ViaDerma, Inc.
LOS ANGELES, April 08, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to provide an update of estimated sales and revenue numbers for the first quarter of 2021, as...
logo.jpg.jpg
ViaDerma, Inc. Announces the Payment of all Toxic Convertible Notes and Has Become Debt Free
March 16, 2021 05:00 ET | ViaDerma, Inc.
LOS ANGELES, March 16, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to announce they have paid off all outstanding toxic convertible debt and the Company is now...
logo.jpg.jpg
ViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practices Operating in Six States
January 21, 2021 05:00 ET | ViaDerma, Inc.
LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announces the completion of a licensing agreement with a group of affiliated wound care medical...